Impact of Frontline Treatment Approach in Patients with Secondary AML and Prior Hypomethylating Agent Exposure: A Retrospective Analysis of 562 Patients with Treated Secondary AML

被引：1
|
作者：
Venugopal, Sangeetha [1 ]
Kadia, Tapan M. [1 ]
Ravandi, Farhad [1 ]
DiNardo, Courtney D. [1 ]
Daver, Naval [1 ]
Borthakur, Gautam [1 ]
Konopleva, Marina [1 ]
Garcia-Manero, Guillermo [1 ]
Montalban-Bravo, Guillermo [1 ]
Maiti, Abhishek [1 ]
Yilmaz, Musa [1 ]
Issa, Ghayas C. [1 ]
Chien, Kelly S. [1 ]
Pierce, Sherry A. [1 ]
Kantarjian, Hagop [1 ]
Short, Nicholas J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153960
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
794
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Determinants of hypomethylation and clinical responses in relapsed/refractory AML patients treated with SGI-110, a novel hypomethylating agent in a phase 1/2 study
    Chung, Woonbok
    Taverna, Pietro
    Lyons, John
    Hao, Yong
    Azab, Mohammad
    Kantarjian, Hagop
    Kropf, Patricia
    Issa, Jean-Pierre
    CANCER RESEARCH, 2015, 75
  • [42] A Phase I/II Study of Combination of Azacitidine, Venetoclax and Pevonedistat in Patients with Newly-Diagnosed Secondary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Hypomethylating Agent (HMA) Failure
    Ong, Faustine
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    Alvarado, Yesid
    Ohanian, Maro
    Konopleva, Marina
    Jabbour, Elias
    Jain, Nitin
    Borthakur, Gautam
    DiNardo, Courtney D.
    Daver, Naval
    Issa, Ghayas C.
    Sasaki, Koji
    Chien, Kelly S.
    Takahashi, Koichi
    Andreeff, Michael
    Muftuoglu, Muharrem
    Delumpa, Ricardo
    Mayor, Ejiroghene
    Loiselle, Christopher
    Waller, Lourdes
    Banks, Glenda
    Kantarjian, Hagop
    Cortes, Jorge E.
    Short, Nicholas
    BLOOD, 2022, 140 : 6206 - 6208
  • [43] Vadastuximab Talirine (33a) plus a Hypomethylating Agent (HMA): A Well-Tolerated Regimen with High Remission Rate in Frontline Older Patients with Acute Myeloid Leukemia (AML)
    Walter, Roland B.
    Fathi, Amir T.
    ANNALS OF HEMATOLOGY, 2017, 96 : S85 - S85
  • [44] A SEER-Medicare Analysis of Treatment Patterns and Outcomes in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agent
    Stein, Eytan
    Latremouille-Viau, Dominick
    Shi, Sherry
    Guerin, Annie
    Wu, Eric
    Bonifacio, Gaetano
    Cao, Xiting
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S314 - S315
  • [45] Retrospective Analysis of Outcomes in Acute Myeloid Leukemia (AML) Patients Exposed to Intravenous Contrast Prior to Stem Cell Transplantation
    Ravi, Gayathri
    Abou-Ismail, Yazan
    Rothgery, Margaret
    Shekar, Anjali
    Golec, Sophie
    de Lima, Marcos
    Tomlinson, Ben
    BLOOD, 2018, 132
  • [46] Retrospective survival analysis of elderly patients with acute myeloid leukemia (AML) treated with aggressive or non aggressive therapy
    Pulsoni, A
    Pagano, L
    Tosti, ME
    Redi, R
    Candoni, A
    Carella, AM
    Cerri, R
    Di Bona, E
    Fabris, P
    Ferrara, F
    Invernizzi, R
    Martino, B
    Miceli, S
    Monaco, M
    Petti, MC
    Villivà, N
    Visani, G
    Mele, A
    Mandelli, F
    BLOOD, 2000, 96 (11) : 503A - 503A
  • [47] A Clinical Analysis of Secondary Surgery in Trigeminal Neuralgia Patients Who Failed Prior Treatment
    Kang, Il Ho
    Park, Bong Jin
    Park, Chang Kyu
    Malla, Hridayesh Pratap
    Lee, Sung Ho
    Rhee, Bong Arm
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2016, 59 (06) : 637 - 642
  • [48] Brivaracetam for the treatment of refractory epilepsy in patients with prior exposure to levetiracetam: A retrospective outcome analysis
    Snoeren, Anniko
    Majoie, Marian H. J. M.
    Fasen, Koen C. F. M.
    Ijff, Dominique M.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2022, 96 : 102 - 107
  • [49] Risk of Secondary Hematological Malignancies in Patients with Follicular Lymphoma: A Retrospective Analysis of 1045 Patients Treated in the Rituximab Era
    Prusila, Roosa Enni Inkeri
    Sorigue, Marc
    Postila, Aleksi
    Salmi, Petteri
    Tanhua, Taru
    Tikkanen, Susanna
    Kakko, Sakari
    Kuitunen, Hanne
    Pollari, Marjukka
    Nystrand, Ilja
    Kuusisto, Milla
    Vasala, Kaija
    Jantunen, Esa
    Korkeila, Eija
    Karihtala, Peeter
    Turpeenniemi-Hujanen, Taina
    Kuittinen, Outi
    BLOOD, 2018, 132
  • [50] Outcome of Patients (pts) Treated for Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (s AML) After Azacitidine (AZA) Failure
    Prebet, Thomas
    Gore, Steven D.
    Esterni, Benjamin
    Itzykson, Raphael
    Thepot, Sylvain
    Beach, C. L.
    Fenaux, Pierre
    Vey, Norbert
    BLOOD, 2010, 116 (21) : 199 - 199
12345